Seres Therapeutics (MCRB) Receivables - Net (2019 - 2025)
Seres Therapeutics (MCRB) has disclosed Receivables - Net for 5 consecutive years, with $157000.0 as the latest value for Q4 2025.
- Quarterly Receivables - Net fell 95.78% to $157000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $157000.0 through Dec 2025, down 95.78% year-over-year, with the annual reading at $157000.0 for FY2025, 95.78% down from the prior year.
- Receivables - Net hit $157000.0 in Q4 2025 for Seres Therapeutics, down from $351000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $7.4 million in Q1 2025 to a low of $157000.0 in Q4 2025.
- Historically, Receivables - Net has averaged $2.4 million across 3 years, with a median of $1.3 million in 2021.
- Biggest five-year swings in Receivables - Net: rose 24.95% in 2021 and later plummeted 95.78% in 2025.
- Year by year, Receivables - Net stood at $1.2 million in 2021, then skyrocketed by 197.92% to $3.7 million in 2024, then tumbled by 95.78% to $157000.0 in 2025.
- Business Quant data shows Receivables - Net for MCRB at $157000.0 in Q4 2025, $351000.0 in Q3 2025, and $7.4 million in Q1 2025.